如何选择mTOR抑制剂?-百灵威

如何选择mTOR抑制剂?

mTOR即雷帕霉素靶蛋白,含有两种复合体,分别为mTORC1和mTORC2。因其是重要的真核细胞信号,调节细胞的生长、凋亡、自噬等,mTOR成为肿瘤治疗的新靶点,mTOR抑制剂已应用于实体瘤、器官移植等疾病研究及治疗中。

图1 mTORC1和mTORC2 <sup>[1]</sup>
图1 mTORC1和mTORC2 [1]

mTOR抑制剂选择见下表:
注:1、IC50: 全称half maximal inhibitory concentration,指物质发挥其最大抑制效果的一半时的浓度。 2、代表抑制作用的强度,抑制作用越强, 越多。 3、表示该化合物对相应的亚型有抑制作用,但暂时无相关数据。
  1. Kathryn G. Foster, Diane C. Mammalian Target of Rapamycin (mTOR): Conducting the Cellular Signaling Symphony. J Biol Chem. 2010 May 7; 285(19): 14071–14077.
1126271
1009298-09-2
AZD-8055, 98%
Description:
a novel ATP-competitive inhibitor of mTOR kinase with an IC50 of 0.8 nM
1239103
1092351-67-1
Torkinib, 98%
Description:
a selective and ATP-competitive mTOR inhibitor with an IC50 of 8 nM,PP242 inhibits both mTORC1 and mTORC2 with IC50s of 30 nM and 58 nM
1497296
1009298-59-2
Vistusertib, 98%
Description:
a novel mTOR inhibitor
1561319
1224844-38-5
Sapanisertib, 98%
Description:
a potent and selective mTOR inhibitor
1562554
1197160-78-3
Gedatolisib, 98%
Description:
a highly potent dual inhibitor of PI3Kα, PI3Kγ, and mTOR with IC50s of 0.4 nM, 5.4 nM and 1.6 nM, respectively. PKI-587 is equally effective in both complexes of mTOR, mTORC1 and mTORC2
1761872
914913-88-5
Palomid 529, 98%
Description:
a novel potent inhibitor of both the mTORC1 and mTORC2
623756
159351-69-6
Everolimus, 95%
Description:
a potent mTOR inhibitor that binds to FKBP-12 to generate an immunosuppressive complex
628156
162635-04-3
Temsirolimus, 99%
Description:
an inhibitor of mTOR with an IC50 of 1.76 μM
916582
371935-74-9
PI-103, 98%
Description:
a potent PI3K/Akt and mTOR inhibitor

促销活动

马“氘”成功,风华绝“代”——龙年J&K试剂助您金“Nature榜”题名

马“氘”成功,风华绝“代”——龙年J&K试剂助您金“Nature榜”题名

百灵威4月满赠活动

百灵威4月满赠活动

【活动】“折”里相遇,进口标准品三折起“go!”

【活动】“折”里相遇,进口标准品三折起“go!”

开学“剂”,来相“惠”——催化剂系列限时活动

开学“剂”,来相“惠”——催化剂系列限时活动

开学“剂”,来相“惠”——氘代试剂系列限时活动

开学“剂”,来相“惠”——氘代试剂系列限时活动